Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) EPS (Weighted Average and Diluted) (2020 - 2025)

Healthcare Triangle filings provide 6 years of EPS (Weighted Average and Diluted) readings, the most recent being -$150.07 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 99.1% to -$150.07 in Q4 2025 year-over-year; TTM through Dec 2025 was -$151.24, a 99.1% increase, with the full-year FY2025 number at -$152.3, up 99.1% from a year prior.
  • EPS (Weighted Average and Diluted) reached -$150.07 in Q4 2025 per HCTI's latest filing, down from -$0.42 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.01 in Q2 2021, with the low at -$16685.2 in Q4 2024.
  • A 5-year average of -$848.37 and a median of -$0.42 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Year-over-year, EPS (Weighted Average and Diluted) plummeted 3880179.07% in 2024 and then skyrocketed 99.23% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.12 in 2021, then plummeted by 2157.76% to -$2.6 in 2022, then soared by 83.44% to -$0.43 in 2023, then plummeted by 3880179.07% to -$16685.2 in 2024, then soared by 99.1% to -$150.07 in 2025.
  • Per Business Quant, the three most recent readings for HCTI's EPS (Weighted Average and Diluted) are -$150.07 (Q4 2025), -$0.42 (Q3 2025), and -$0.58 (Q2 2025).